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he COOH-terminal A168–170 region of the giant
sarcomeric protein titin interacts with muscle-speciﬁc
RING ﬁnger-1 (MURF-1). To investigate the functional
signiﬁcance of this interaction, we expressed green ﬂuores-
cent protein fusion constructs encoding deﬁned fragments
of titin’s M-line region and MURF-1 in cardiac myocytes.
Upon expression of MURF-1 or its central region (containing
its titin-binding site), the integrity of titin’s M-line region
was dramatically disrupted. Disruption of titin’s M-line
region also resulted in a perturbation of thick ﬁlament
components, but, surprisingly, not of the NH
 
2
 
-terminal or
I-band regions of titin, the Z-lines, or the thin ﬁlaments.
This speciﬁc phenotype also was caused by the expression
T
 
of titin A168–170. These data suggest that the interaction of
titin with MURF-1 is important for the stability of the sar-
comeric M-line region. 
MURF-1 also binds to ubiquitin-conjugating enzyme-9 and
isopeptidase T-3, enzymes involved in small ubiquitin-related
modiﬁer–mediated nuclear import, and with glucocorticoid
modulatory element binding protein-1 (GMEB-1), a transcrip-
tional regulator. Consistent with our in vitro binding data
implicating MURF-1 with nuclear functions, endogenous
MURF-1 also was detected in the nuclei of some myocytes.
The dual interactions of MURF-1 with titin and GMEB-1
may link myoﬁbril signaling pathways (perhaps including
titin’s kinase domain) with muscle gene expression.
 
Introduction
 
Numerous structural and regulatory proteins are assembled
and maintained in an exquisitely precise order within the
myofibrils of striated muscle, yet the molecular mechanisms
responsible for this phenomenon are not well understood.
The principal components of muscle sarcomeres, the basic
contractile units of myofibrils, include parallel arrays of
actin-containing thin filaments that overlap with myosin-
containing thick filaments. A third filament system is
formed by single molecules of titin (connectin), the largest
vertebrate protein identified to date (mol wt 
 
 
 
3–3.7 MD)
(Maruyama et al., 1977; Wang et al., 1979; Labeit and
Kolmerer, 1995; Bang et al., 2001). Titin molecules from
adjacent sarcomeres overlap in the Z-line, and those from
opposite half sarcomeres overlap in the M-line, thus forming
a continuous filament system within myofibrils (Obermann
et al., 1996; Gregorio et al., 1999). The majority (
 
 
 
90%) of
the titin molecule is comprised of repeating modular do-
mains from the fibronectin (FN)* type III and the immuno-
globulin (Ig) superfamilies. Additionally, there are 17 unique
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insertions distributed along the length of titin, including a
serine/threonine kinase domain in its M-line region (Labeit et
al., 1992), the function of which remains elusive.
To dissect the functional properties of titin’s domains, re-
cent investigations have focused on searching for novel titin-
binding proteins. One of these proteins is muscle-specific
RING finger-1 (MURF-1) (Centner et al., 2001), also re-
cently identified as striated muscle RING zinc finger (SMRZ)
(Dai and Liew, 2001) and RING finger 28 (RNF 28)
(see http://www.gene.ucl.ac.uk/cgi-bin/nomenclature/search-
genes.pl). This protein binds to the titin domains A168–169–
170 (A168–170) located directly NH
 
2
 
-terminal to the titin
kinase domain (Centner et al., 2001). Two proteins with a
high degree of homology to MURF-1 also have been identi-
fied: MURF-2 (RNF 29) and MURF-3 (RNF 30) (Spencer et
al., 2000; Centner et al., 2001). The three MURFs are mem-
bers of the RING finger-B-box-coiled-coil (RBCC) family, a
class of proteins that have critical roles in cellular processes in-
cluding signal transduction, gene transcription, ubiquitina-
tion, and differentiation (for reviews see Freemont, 2000;
Borden, 2000). Structurally, the MURFs contain a Zn-bind-
ing RING finger domain at their extreme NH
 
2
 
-terminal end,
a MURF family–specific conserved region, a B-box domain,
coiled-coil motifs, and an acidic tail (Spencer et al., 2000;
Centner et al., 2001; Dai and Liew, 2001).
To date, little insight into the cellular roles of the MURFs
is available. In vitro binding studies revealed that MURF
family members homo- and hetero-oligomerize (Centner et
al., 2001). MURF-3 appears to associate with microtubules
and have a role in myogenic differentiation and microtubule
stabilization (Spencer et al., 2000). MURF-1 (SMRZ) re-
cently has been shown to interact with small ubiquitin-
related modifier-3 (SUMO-3/SMT3b; Dai and Liew, 2001),
a member of a ubiquitin-related class of proteins implicated
in subcellular targeting and nuclear import (for review on
SUMO proteins see Melchior, 2000). Consistent with this
finding, MURF-1 is detected in nuclei (Dai and Liew, 2001;
this study). In a different study, it was determined that
MURF-1 appears to be the only MURF family member that
interacts directly with titin, within the M-line region of the
sarcomere (Centner et al., 2001). Despite these recent stud-
ies, the exact physiological role(s) of the MURF family mem-
bers, particularly MURF-1 and -2, have remained elusive.
To determine which regions of MURF-1 target to myo-
fibrils and/or nuclear sites, and as an initial approach to de-
cipher the cellular properties of MURF-1, we expressed
green fluorescent protein (GFP) fusion constructs encoding
defined regions of MURF-1 and its titin-binding site,
A168–170, in live cardiac myocytes. Our data suggest that
the interaction of titin with the central region of MURF-1 is
important for maintaining the integrity of titin’s M-line
structure. In turn, titin’s COOH-terminal (M-line) region
appears to be necessary for thick filament integrity, but, sur-
prisingly, not for the integrity of titin’s NH
 
2
 
-terminal or
I-band region, the thin filaments, or the Z-lines.
Intriguingly, endogenous MURF-1 also was detected in the
nuclei of some myocytes. Consistent with this observation, in
vitro interaction studies revealed that MURF-1 binds to ubiq-
uitin-conjugating enzyme 9 (Ubc9) and isopeptidase T-3
(ISOT-3), enzymes involved in SUMO modification of target
proteins, a posttranslational modification that occurs in the
nucleus. Our in vitro interaction studies also demonstrated
that MURF-1 is capable of binding to glucocorticoid modula-
tory element binding protein-1 (GMEB-1), a nuclear protein
implicated in transcriptional regulation (Theriault et al.,
1999; Jimenez-Lara et al., 2000; Zeng et al., 2000b). There-
fore, our data suggest MURF-1 has an important role in titin
filament M-line structure (and perhaps in titin kinase-based
signaling processes) as well as a nuclear function (potentially
in the control of muscle gene expression). Future studies will
likely provide insights into how the dual functions of MURF-1
are associated, as well as how myofibrillogenesis and the regu-
lation of muscle gene expression are linked.
 
Results
 
MURF-1 has multiple subcellular localizations in 
cardiac myocytes
 
Previous immunolocalization studies revealed that in adult
striated muscle, MURF-1 is distributed diffusely throughout
the cytoplasm, is assembled at the Z-line region, and is at the
M-line region where its binding partner, titin A168–170, is
located (Centner et al., 2001). We used primary cultures of
fetal rat and embryonic chick cardiac myocytes in studies de-
Figure 1. MURF-1 is detected in the M-line region of the sarco-
mere, diffuse in the cytoplasm, and in nuclei in fetal rat cardiac 
myocytes. Rat cardiac myocytes were labeled with polyclonal anti–
MURF-1 antibodies followed by Texas red–conjugated secondary 
antibodies (a, c, and e), and with monoclonal  -actinin antibodies 
followed by Cy2-conjugated secondary antibodies (b and d). DAPI 
stain was added to identify nuclei (f). Note, inset in b is a merged 
image of MURF-1 (red) and  -actinin (green) staining. MURF-1 
staining in the M-line region (a, double arrows), diffuse (c and e, 
arrowheads), and/or in nuclei with varying staining intensities 
(a and e). N, nucleus. Bars, 10  m. 
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signed to investigate the cellular role of the interaction of
MURF-1 with titin. When these cells were stained with
anti–MURF-1 antibodies, MURF-1 was detected diffusely
throughout the cytoplasm, and was assembled at the M-line
region (Fig. 1; data from rat myocytes shown). Costaining
for 
 
 
 
-actinin, which stains all myofibrils, revealed that in
some myocytes, MURF-1 assembled in only a few myo-
fibrils, whereas in other myocytes, it was assembled in all
myofibrils (Fig. 1 a, arrows). Consistent with this observa-
tion, immunolocalization studies on isolated rat cardiac and
skeletal muscle myofibrils also demonstrated that MURF-1
was detected at the M-line region in only a portion of myo-
fibrils (30–50%; unpublished data). Interestingly, although
MURF-1 was detected at the M- and the Z-line in adult car-
diac tissue sections (Centner et al., 2001), MURF-1 was not
detected at the Z-line in rat fetal or chick embryonic cardiac
myocytes. The significance of this is not known, but may be
due to developmental differences. MURF-1 staining was
also observed diffuse in the cytoplasm (Fig. 1, c and e, ar-
rowheads) and at varying intensities in the nuclei of some
cardiac myocytes, as shown by colocalization with DAPI
staining (Fig. 1, e and f); this was confirmed by scanning at
different focal planes by deconvolution microscopy (unpub-
lished data). MURF-1’s nuclear localization is consistent
with a recent study that detected MURF-1 (SMRZ) fusion
proteins in the nuclei of C2C12 skeletal muscle cells (Dai
and Liew, 2001). Staining with the secondary antibody
alone yielded negligible background in all experiments (un-
published data).
 
Expression of MURF-1 or titin A168–170 disrupts 
the integrity of titin’s M-line region and the 
organization of thick filament components.
 
We generated a GFP–MURF-1 fusion construct for expression
studies in chick cardiac myocytes (Fig. 2). Confirming the
immunolocalization studies, GFP–MURF-1 assembled in a
Figure 2. The COOH-terminal region of titin, revealing its Ig, 
FN III, and Ser/Thr kinase domains (modified from Centner et al., 
2001). Most of the full-length titin molecule is composed of repeating 
Ig (dark gray) and FN III (red) modules, but also contains 17 unique 
domains, including a Ser/Thr kinase domain at the M-line region 
(light gray). The MURF-1 binding site resides within the Ig and FN 
domains A168–170, just NH2-terminal to the kinase domain. Bars 
above the titin molecule denote constructs used. Schematic struc-
ture of MURF-1 shown under titin, including its RING domain 
(orange), MURF family conserved region (purple), B-box domain 
(green), coiled-coil domains (yellow), and tail region (blue). The 
titin A168–170 binding site is located within the central region of 
MURF-1. The GFP–MURF-1 deletion constructs are shown under 
full-length MURF-1.
Figure 3. Expression of GFP–MURF-1 results in severe 
disruption of titin’s M-line structure. Cells expressing 
GFP–MURF-1 (c) or GFP alone (a) were stained with anti-
titin A168–170 antibodies followed by Texas red–
conjugated secondary antibodies (b and d). In most 
myocytes, GFP–MURF-1 expression resulted in a severe 
disruption of the M-line region of titin (d) compared with 
myocytes expressing GFP alone (b). Note, titin staining 
colocalized with many of the GFP–MURF-1 aggregates 
(c and d, arrowheads). The disruption of titin appears to 
be localized to its COOH-terminal region. Triple-labeling 
studies in GFP- (e) and GFP–MURF-1–expressing (h) cells 
revealed that epitopes from the NH2-terminal region of 
titin (j) appeared regular and striated in the same myofibrils 
exhibiting disrupted COOH-terminal titin staining (i). 
Double arrows mark regular, striated titin and single 
arrows mark disrupted titin. Bars, 10  m. 
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portion of myofibrils at the M-line region and colocalized
with anti-titin A168–170 staining (unpublished data). GFP–
MURF-1 was also diffusely distributed and in distinct ag-
gregates (of varying size and intensity) in the cytoplasm of
transfected myocytes (Fig. 3 c, arrowheads), as well as in
contaminating fibroblasts that normally do not express
MURF-1 (unpublished data). These aggregates are likely a re-
sult of homo-oligomerization, which has been reported previ-
ously with MURF proteins (Spencer et al., 2000; Centner et al.,
2001). Titin staining also colocalized with some GFP–MURF-1
aggregates in the cytoplasm of myocytes (Fig. 3, c and d, arrow-
heads) perhaps because the MURF-1 aggregates provided addi-
tional binding sites for titin during myofibril assembly or turn-
over. GFP–MURF-1 also was observed in the nuclei of some
myocytes (unpublished data). Strikingly, the majority of the
GFP–MURF-1–transfected cells exhibited severe disruption of
the COOH-terminal region of titin compared with cells ex-
pressing GFP alone (Fig. 3, b and d, arrows).
Figure 4. Expression of GFP–MURF-1 also perturbs the organization of thick filament components. Transfected myocytes were stained 
with antibodies to myosin (b and d), MyBP-C (f and h), and myomesin (j and l). In many GFP–MURF-1–expressing myocytes, staining for 
thick filament components was perturbed (d, h, and l), compared with myocytes transfected with GFP alone (b, f, and j). Single arrows mark 
perturbed thick filament component staining, and double arrows mark regular, striated thick filament staining. Note, size and intensity of the 
GFP–MURF-1 cytoplasmic aggregates vary from cell to cell (c, g, and k, arrowheads). Bar, 10  m.
 
Surprisingly, triple-labeling studies revealed that although
titin’s COOH-terminal region was disrupted in GFP–
MURF-1–expressing myocytes, titin’s NH
 
2
 
-terminal region
appeared in a regular, striated pattern in the identical myo-
fibrils (Fig. 3, i and j). However, staining transfected cells for
myosin, myosin-binding protein C (MyBP-C), and myo-
mesin demonstrated that GFP–MURF-1 expression also
perturbed thick filament integrity in a large percentage of
transfected myocytes (Fig. 4). Specifically, 
 
 
 
80–90% of
cells transfected with MURF-1 had disrupted COOH-ter-
minal titin structure, whereas 
 
 
 
60–70% of the cells had
perturbed thick filament structure (Fig. 6). This difference
in percentages of cells affected suggests that the thick fila-
ment perturbation may be a secondary effect of the disrup-
tion of titin’s M-line region. Unexpectedly, the structure of
the actin (thin) filaments, the I-band region of titin, and the
Z-lines (as assessed by the distribution of phalloidin, titin
N2A, and 
 
 
 
-actinin staining, respectively) appeared in typi-
 
Table I. 
 
Subcellular localization of GFP–MURF-1 deletion constructs in cardiac myocytes
 
a
 
GFP–MURF-1 deletion construct Cytoplasmic aggregates  Striated at M-line region Nuclei
 
%% %
 
GFP alone 0 0 40–65
RING 0 0 100
Tail 0 0
 
 
 
10
Tailless 90–95 30–40 40–65
RINGless 90–95 30–40 0
Central 90–95 10–20 0
 
a
 
Represents the total percentage of transfected myocytes observed to contain GFP fusion proteins in the specified localization. 
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cal striated patterns in the majority of GFP–MURF-1–
transfected cells (Figs. 5 and 6), even though the COOH-
terminal region of titin was disrupted (Fig. 5, i and j).
Because MURF-1 was shown to interact with the
COOH-terminal titin domains A168–A170 (Centner et al.,
2001), we also performed expression studies with titin GFP
fusion constructs encoding the A168–170 region or its
flanking regions for comparison (Fig. 2). When expressing
titin A168-170–GFP in myocytes, both the M-line region of
titin (Fig. 7 b) and the thick filaments (Fig. 7 h; data shown
for myomesin, similar results were obtained for myosin and
MyBP-C) were perturbed. Consistent with the results from
the GFP–MURF-1 expression studies, Z-line and thin fila-
ment structure appeared in their characteristic patterns in
the titin A168-170–GFP–transfected cells (Fig. 7, n and t).
In contrast, myocytes expressing other titin M-line regions
(the Ig domains located COOH-terminal to the A168–170
region, M1-M2-M3–GFP or M8-M9-M10–GFP) had reg-
ular, striated staining patterns for titin, thick filament,
Z-line, and thin filament components (Fig. 7, d, j, p, and v;
data shown for M8-M9-M10-GFP). Furthermore, myocytes
expressing GFP fusion constructs encoding titin’s unique
Ser/Thr kinase domain, as well as those expressing a consti-
tutively activated mutant form of this domain, exhibited
typical titin, thick filament, thin filament, and Z-line stain-
ing (Fig. 7, f, l, r, and x; data shown for titin kinase–GFP).
In conclusion, the disruption of sarcomeric M-line integrity
was specific to the expression of titin A168–170 and its
ligand, MURF-1. These data suggest that the interaction of
titin with MURF-1 has an important role in maintaining
the structure of sarcomeric M-line components in cardiac
myocytes. Our data also surprisingly indicate that disruption
of the integrity of the COOH-terminal region of titin per-
turbs thick filament structure but does not appear to affect
the structure of titin’s I-band or NH
 
2
 
-terminal regions, the
thin filaments, or the Z-lines.
 
MURF-1’s central region targets to the M-line 
and maintains M-line structure, whereas the RING 
domain targets to nuclei
 
To investigate the regions of MURF-1 involved in its
subcellular targeting and maintaining the structure of
titin’s COOH-terminal region, we generated five GFP–
MURF-1 deletion constructs (Fig. 2). One construct en-
coded the MURF-1 NH
 
2
 
-terminal RING domain alone
(RING), which contains the SUMO-3/SMT3b binding
site (Dai and Liew, 2001). Another construct encoded
only the COOH-terminal acidic tail region (Tail). Three
constructs contained the central region of MURF-1,
which binds to titin A168–170 (Centner et al., 2001):
one encoded the NH
 
2
 
-terminal RING domain plus the
central region (Tailless); one encoded the central region
Figure 5. Expression of GFP–MURF-1 does not appear to affect the 
integrity of thin filament or Z-line components. Myocytes expressing 
GFP–MURF-1 (c) or GFP alone (a) were stained for Z-lines with saro-
meric  -actinin antibodies (b and d) and show regular, striated staining. 
Triple-labeling studies in GFP–MURF-1–transfected cells (h), using 
Texas red–conjugated phalloidin (j) and antibodies to titin A168–170 
(i), determined that thin filament integrity is not affected upon 
disruption of COOH-terminal titin in identical myofibrils. GFP-
transfected cells (e) exhibited normal actin filament (g) and COOH-
terminal titin (f) staining. Double arrows mark regular, striated staining. 
Single arrows mark disrupted titin staining. Bars, 10  m.
Figure 6. Quantification of GFP–MURF-1– and GFP-expressing 
myocytes exhibiting disrupted staining patterns for sarcomeric 
components. Myocytes expressing GFP–MURF-1 (gray bars) or GFP 
alone (white bars) were stained for various sarcomeric components, 
and the number of cells exhibiting perturbed staining patterns was 
counted. The results indicate that the COOH-terminal region of titin 
(A168–170 and AB5) was severely disrupted in most GFP–MURF-1–
expressing cells, whereas its I-band (N2A) and NH2-terminal region 
(T11) were not affected. The thick filament components myosin, 
myomesin, and C-protein were also disrupted in a large majority 
of GFP–MURF-1–expressing cells, but thin filament and Z-line 
components appear relatively unaffected. Data are presented as 
the mean percentage of total myocytes with disrupted staining   SD. 
Means were obtained by counting  50 myocytes from more than 
two experiments and the results are representative of  10 experiments. 
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plus the COOH-terminal tail (RINGless); and one en-
coded the MURF-1 central region alone (Central). Nei-
ther RING nor Tail were observed to assemble at the sar-
comeric M-line region or form cytoplasmic aggregates.
Strikingly, however, RING–GFP was detected in the nu-
clei of all transfected myocytes observed (Table I). Be-
cause aberrant nuclear localization of GFP fusion pro-
teins is known to occur, we quantified the nuclear
localization of each GFP–MURF-1 fusion protein in
transfected myocytes (Table I). RING–GFP localized to
nuclei in 100% of observed cells, compared with GFP
alone, which was observed in nuclei in 40–65% of cells.
Consistent with this, RINGless–GFP never exhibited
nuclear localization, but Tailless-GFP (containing the
RING domain) was detected in nuclei in 40–65% of cells
(Table I). Finally, Tail–GFP was detected in 
 
 
 
10% of
myocyte nuclei, suggesting that it does not contain a fully
functional nuclear targeting site. These data, together
with the observations that MURF-1’s RING domain
binds to the nuclear protein SUMO-3 (Dai and Liew,
2001) and other RING proteins have been reported in
nuclei (for review see Borden, 2000), are consistent with
the RING domain targeting MURF-1 to the nuclei of
cardiac myocytes.
In contrast, all three constructs encoding MURF-1’s cen-
tral region (Tailless, RINGless, and Central) assembled at
the M-line region in a portion of myofibrils of some myo-
cytes (Table I). Additionally, the expressed proteins all
formed cytoplasmic aggregates in the majority of transfected
cells, most likely due to their coiled-coil domains. These
data indicate that MURF-1’s central region, containing
the titin-binding site, targets the protein to the sarcomeric
M-line region, whereas the RING domain appears to target
it to nuclei.
Next, we costained transfected myocytes with anti–
COOH-terminal titin antibodies to identify the region(s) of
MURF-1 involved in M-line structure. Expression of each of
the three MURF-1 fragments containing its central region,
shown above to contain an M-line targeting site, resulted in
a phenotype identical to that observed when full-length
MURF-1 was expressed. Specifically, a marked disruption of
titin A168–170 staining was observed in the vast majority of
cells expressing Central, Tailless, or RINGless (Fig. 8, f, h,
and j), compared with regular, striated titin staining in myo-
cytes expressing RING or Tail (Fig. 8, b and d). These studies
reveal that MURF-1 contains two distinct targeting and func-
tional domains. Its central region, containing the titin-bind-
ing site, targets it to the M-line and participates in maintain-
Figure 7. Expression of titin domains 
A168–170 also disrupts titin M-line 
region and thick filament structure, but 
not thin filaments or Z-lines. Myocytes 
expressing titin A168–170 or other Ig 
domains from the M-line region of titin 
were stained for various sarcomeric 
components. Costaining of A168-170–
GFP expressing myocytes with anti–
C-terminal titin region antibodies 
revealed a severe disruption of titin 
(a and b), compared with myocytes 
transfected with M8-M9-M10-GFP 
(c and d) or titin kinase–GFP (e and f). 
Costaining of titin A168-170–transfected 
myocytes with antibodies against thick 
filament components, including myo-
mesin (g and h), reveals that the integrity 
of the thick filaments is perturbed com-
pared with myocytes transfected with 
titin M8-M9-M10-GFP (i and j) or titin 
kinase–GFP (k and l). Myocytes trans-
fected with titin A168-170–GFP (m, n,
s, and t), titin M8-M9-M10–GFP (o, p, 
u, and v), or titin kinase–GFP (q, r, w, and 
x) were stained with Texas red–conjugated 
phalloidin (n, p, and r) or antibodies to 
sarcomeric  -actinin (t, v, and x). Double 
arrows mark regular, striated staining. 
Single arrows mark disrupted staining. 
Bars, 10  m. 
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ing the integrity of titin’s COOH-terminal region. The
RING domain, containing the binding site for SUMO-3, ap-
pears to be involved in MURF-1 nuclear targeting.
 
MURF family members interact with Ubc9 and ISOT-3, 
but only MURF-1 interacts with the transcriptional 
modulator GMEB-1
 
Previous binding studies revealed that MURF-1 interacts
with titin A168–A170 and with itself (by oligomerization),
and also hetero-oligomerizes with MURF-2 and -3 (Centner
et al., 2001). Other in vitro interaction studies determined
that MURF-1 also binds to SUMO-3/SMT3b (Dai and
Liew, 2001). We searched for additional MURF binding
proteins in human heart and fetal mouse cDNA libraries by
yeast two-hybrid (Y2H) screening. These novel screens dem-
onstrated that both MURF-1 and -2 baits interact with
Ubc9 and ISOT-3 prey clones (Fig. 9 A). Ubc9 is an en-
zyme involved in SUMO modification; it specifically cata-
lyzes the formation of an isopeptide bond between SUMO
Figure 8. The central portion of 
MURF-1 is involved in maintaining 
the structure of COOH-terminal titin. 
Myocytes expressing defined regions 
of MURF-1 were stained with anti-titin 
A168–170 antibodies. Expression of 
the RING–GFP (a and b) or Tail–GFP 
(c and d) proteins did not appear to 
affect the integrity of COOH-terminal 
titin. Expression of GFP fusion proteins 
of the central MURF region (Central; 
i and j), the RING plus central regions 
(Tailless; g and h), and the central plus 
tail regions (RINGless; e and f) severely 
disrupted titin’s COOH-terminal region (single arrow marks disrupted titin A168–170 staining; 
double arrows mark regular, striated titin A168–170 staining). Note that titan staining 
colocalized with many of the GFP–MURF-1 aggregates (g–j, arrowheads). Bar, 10  m.
 
Figure 9.
 
MURF family members interact with SUMO modifying 
enzymes ISOT-3 and Ubc9, but only MURF-1 interacts with the 
transcriptional regulator GMEB-1.
 
 (A) Y2H screens using full-length 
cDNAs of individual MURF family members as baits identified 
ISOT-3 (light gray) and Ubc9 (black) as MURF-binding proteins. 
However, GMEB-1 (dark gray) was found to interact only with 
MURF-1. 
 
 
 
-Galactosidase assays were performed to confirm 
positive clones, and the levels were compared with colonies trans-
formed with each prey construct and the empty bait vector (white). 
Data are presented as mean levels of 
 
 
 
-galactosidase from triplicate 
experiments 
 
 
 
 SD. ***, 
 
P
 
 
 
  
 
0.001. (B) RT-PCR analysis of human 
heart total RNA revealed that GMEB-1 mRNA transcripts are 
detectable in heart (H) and skeletal (Sk) tissues. Lane 1, no reverse 
transcriptase control in human heart RNA (
 
 
 
); lane 2, 511-bp 
GMEB-1 PCR product amplified from human heart RNA (
 
 
 
); lane 3, 
511-bp GMEB-1 PCR product amplified from human skeletal RNA 
(
 
 
 
); lane 4, no reverse transcriptase control in human skeletal RNA 
(
 
 
 
). (C) GMEB-1 specifically binds to MURF-1 in GST pull-down 
assays. GMEB-1 was translated in vitro (lane 3). When incubated with 
bacterially expressed GST–MURF-1 fusion peptides, GMEB-1 and 
MURF-1 binding to glutathione–sepharose 4B beads was detectable 
(lane 2). Lane 1 contains no detectable binding of GMEB-1 to the 
beads alone. IVT, in vitro translated. (D) GMEB-1–GFP targets to the 
nuclei of cardiac myocytes (a and c). MURF-1 staining also was 
present in some of the nuclei that contained GMEB-1–GFP (b). Note, 
MURF-1 is also detected at the M-line region in the same myocytes 
(b, double arrows). Expression of GMEB-1–GFP in cardiac myocytes 
does not appear to affect the integrity of the COOH-terminal region 
of titin (d, staining with anti-titin A168–170 antibodies). Double 
arrows mark regular, striated titin staining. N, nuclei. Bars, 10 
 
 
 
m. 
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and a target protein (Desterro et al., 1997; Johnson et al.,
1997; Tatham et al., 2001). ISOT-3 is a member of an en-
zyme family responsible for cleaving isopeptide bonds. It has
been proposed that Ubc9 and isopeptidases regulate the dy-
namics of SUMO modification (for review see Melchior,
2000; Muller et al., 2001). Further Y2H studies revealed
that MURF-3 also interacts with Ubc9 (Fig. 9 A).
Interestingly, another MURF-1 binding partner that we
identified through Y2H screens is GMEB-1 (Fig. 9 A).
GMEB-1 is a nuclear protein that regulates transcription in
response to changes in cellular glucocorticoid levels (Zeng et
al., 1998, 2000b; Jimenez-Lara et al., 2000). Remarkably,
GMEB-1 binding to MURF-2 or -3 was not detected in the
Y2H system (Fig. 9 A), although these proteins are highly
homologous to MURF-1. The interaction of MURF-1 with
GMEB-1 was confirmed by glutathione-
 
S
 
-transferase (GST)
pull-down assays under stringent conditions (Fig. 9 C). Pre-
viously, GMEB-1 mRNA was found in skeletal muscle but
not in cardiac tissue by RT-PCR studies (Zeng et al., 2000a).
However, it was detected in heart by Northern and Western
blot analysis (Theriault et al., 1999; Jimenez-Lara et al.,
2000). We performed RT-PCR analysis on heart and skele-
tal cDNA and detected GMEB-1 mRNA transcripts in
both tissues (Fig. 9 B). (The discrepancy between our study
and the Zeng et al., 2000a study might be due to differ-
ences in PCR conditions.) GMEB-1–GFP fusion proteins
localized to nuclei in transfected myocytes (Fig. 9 D, c),
consistent with previous studies in COS and HeLa cells
(Theriault et al., 1999; Jimenez-Lara et al., 2000). In a few
myocytes, GMEB-1 also was detected diffusely throughout
the cytoplasm (Fig. 9 D, c), but assembly at the M-line re-
gion of the sarcomere was never observed. Costaining myo-
cytes expressing GMEB-1–GFP with anti–MURF-1 anti-
bodies demonstrated that GMEB-1–GFP and MURF-1
were both present in the same nuclei of some myocytes
(Fig. 9 D, a and b), which also supports their potential in-
teraction. Finally, cells expressing GMEB-1–GFP exhibited
regular striated staining patterns for titin, thin filament,
thick filament, and Z-line components, indicating that the
overall sarcomeric integrity in the GMEB-1–transfected
cells was not affected (Fig. 9 D, d; data shown for COOH-
terminal titin staining). These data suggest that MURF-1
specifically interacts with GMEB-1. However, unlike exog-
enous expression of MURF-1, exogenous expression of
GMEB-1 does not affect the integrity of the M-line region
of cardiac sarcomeres.
 
Discussion
 
In recent years, there has been significant progress in deci-
phering the structure and functions of the giant sarcomeric
protein titin. It appears that titin, the only known protein to
span the entire half sarcomere, has multiple cellular roles.
Titin contains elastic elements in its I-band region responsi-
ble for passive tension generated upon stretch; thus it func-
tions as a molecular spring to maintain the structural integ-
rity of contracting myofibrils. Additionally, titin may act as a
“molecular blueprint” to orchestrate the assembly and orga-
nization of the thick filaments as well as other structural and
regulatory components of sarcomeres. The presence of a
unique Ser/Thr kinase domain at the COOH-terminal end
of titin also suggests that it may participate in signal trans-
duction pathways (for reviews with original citations see La-
beit et al., 1997; Gregorio et al., 1999; Trinick and
Tskhovrebova, 1999; Gregorio and Antin, 2000).
To decipher the roles of titin in sarcomeric structure, recent
studies have focused on dissecting the properties of individual
titin regions and their potential ligands (for reviews see McEl-
hinny et al., 2000; Sanger and Sanger, 2001). Here, we aimed
to investigate the functional significance of the interaction of
titin’s COOH-terminal Ig domains A168–170 (located di-
rectly NH
 
2
 
-terminal to the titin Ser/Thr kinase domain) with
MURF-1, a RING finger protein. Expression of MURF-1 or
titin A168–170 in primary cultures of embryonic chick car-
diac myocytes severely disrupted the integrity of titin’s M-line
region. The region of MURF-1 that is responsible for this
phenotype was mapped to its central region, which previously
has been shown to contain its titin-binding site (Centner et
al., 2001). The most plausible explanation for our observa-
tions is that a dominant-negative phenotype occurred. That
is, upon expression of the central region of MURF-1 or titin
A168–170, the fusion proteins likely interfered with the inter-
action of endogenous MURF-1 with titin. Surprisingly, ex-
pression of the full-length MURF-1 molecule also resulted in
this striking phenotype, suggesting that endogenous MURF-1
levels are tightly regulated. Our data suggest that MURF-1
and its interaction with titin A168–170 are critical for main-
taining the stability of titin’s COOH-terminal region.
In turn, it appears that the interaction of titin with
MURF-1 plays a critical role in maintaining the stability of
the thick filaments. Although all of the sarcomeric compo-
nents comprising the M-line region have not been eluci-
dated, the thick filaments appear to be laterally associated
with titin via their interactions with MyBP-C (along the
A-band), and myomesin (at the M-line) (Houmeida et al.,
1995; Obermann et al., 1997). In fact, it has been proposed
that titin specifies the number and location of thick filament
components (Whiting et al., 1989; Trinick, 1994; Hou-
meida et al., 1995). It is striking that expression of titin
A168–170 in cardiac myocytes perturbed M-line titin and
thick filament structure, yet expression of other titin
COOH-terminal domains (M1-M2-M3, M8-M9-M10,
titin kinase domain, or a mutant, constitutively active kinase
domain) had no effect on M-line or thick filament integrity.
These results specifically implicate titin A168–170 and
MURF-1 in the regulation of sarcomeric M-line and thick
filament organization. We hypothesize that MURF-1 forms
a complex with titin A168–170 that functions in the assem-
bly of M-line and thick filament components during myofi-
brillogenesis, as well as in myofibril turnover.
Intriguingly, although titin’s COOH-terminal region and
the thick filaments were disrupted in MURF-1 or titin
A168-170–transfected myocytes, the structural integrity of
the thin filaments remained intact. These data are consistent
with the observation that thin filament assembly occurs in-
dependently of the formation of the thick filaments (Antin
et al., 1981; Schultheiss et al., 1990; Epstein and Fischman,
1991; Holtzer et al., 1997; Ehler et al., 1999; Gregorio and
Antin, 2000; Rudy et al., 2001). Because titin’s NH
 
2
 
-termi-
nal and I-band regions were also intact, these data indicate 
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that certain regions of the titin filament can be “selectively”
perturbed. Previous studies have shown that titin interacts
with various Z-line components (
 
 
 
-actinin and T-cap/tele-
thonin) and thin filament components (actin) (Funatsu et
al., 1993; Jin, 1995; Granzier et al., 1997; Linke et al.,
1997; Sorimachi et al., 1997; Gregorio et al., 1998; Mues et
al., 1998; Young et al., 1998). From our studies, it appears
that these associations along the titin molecule stabilize its
NH
 
2
 
-terminal and I-band regions even when the structure
of its COOH-terminal end is perturbed. Consistent with
this idea, the NH
 
2
 
-terminal end of titin becomes organized
during myofibril assembly before the COOH-terminal end
of titin and other M-line components (Fürst et al., 1989;
Schultheiss et al., 1990; Komiyama et al., 1993; van der
Loop et al., 1996; Ehler et al., 1999; Rudy et al., 2001). A
possible explanation for this observation is that the less orga-
nized M-line region of titin filaments may not be concen-
trated enough for a signal to be detected by immunofluores-
cence microscopy (Ehler et al., 1999). Therefore, in our
study, it is likely that titin’s COOH-terminal region lost its
stable interactions and was “less organized,” whereas the
more NH
 
2
 
-terminal regions remained “bolted” to other Z-
and I-band components. Interestingly, another study has
demonstrated that the thick filaments remain intact when
the thin filaments are perturbed upon expression of titin’s
I-band, N2B region (Linke et al., 1999), in the same cell type
used in our studies. Thus, titin also may function to keep
the thick filaments aligned in the absence of thin filaments.
In addition to sarcomeric M-line localization, endogenous
MURF-1 was detected in the nuclei of cardiac myocytes.
The observation that MURF-1 assembles in only some myo-
fibrils also indicates that its cellular levels are tightly regu-
lated. An excellent candidate for regulating MURF-1 levels,
its localization pattern, and nuclear import is SUMO-3.
SUMO-3 binds to MURF-1’s RING domain (Dai and
Liew, 2001), the region of MURF-1 that appears to be in-
volved in its nuclear localization (this study). We found that
two enzymes potentially involved in regulating the conjuga-
tion of SUMO with its target proteins, Ubc9 and ISOT-3,
interact with MURF-1 and other MURF family members.
Although the biochemical pathways and classes of enzymes
involved in “SUMO modification” are parallel to those in
ubiquitination, the two processes may be functionally dis-
tinct. In fact, SUMO modification has been implicated in
regulating the levels and localization patterns of target pro-
teins, including nuclear localization (for review see Mel-
chior, 2000). All three MURF proteins exhibit multiple cel-
lular localization patterns (Spencer et al., 2000; Centner et
al., 2001; unpublished data), consistent with them being po-
tential SUMO targets. Interestingly, SUMO-3 has recently
been shown to be a key component of a new class of acute
and reversible cellular stress response pathways (Saitoh and
Hinchey, 2000). Further studies are needed to determine
whether MURF-1 levels and/or localization patterns change
in response to cellular stress, and whether titin plays a role in
sensing stress response pathways in cardiac myocytes.
Strongly implicating MURF-1 with nuclear functions are
the data demonstrating its specific interaction with GMEB-1
and their colocalization in the nuclei of some myocytes.
GMEB-1 was first characterized as a component of a com-
plex that binds to the GME in liver cells, thereby modulat-
ing transcription in response to glucocorticoid levels (Zeng
et al., 1998; Theriault et al., 1999). Recent studies indicate
that GMEB-1 is expressed in a wide range of cell types and
may have roles in development and differentiation (Zeng et
al., 2000a). We confirmed that GMEB-1 mRNA transcripts
are present in striated muscle tissue and found that GMEB-
1–GFP fusion proteins targeted to the nuclei of transfected
cardiac myocytes. Given that MURF-1 is involved both in
sarcomeric M-line structure (via its interaction with titin)
and potentially in gene expression (via its interaction with
GMEB-1), we speculate that MURF-1 acts as a link between
gene expression and myofibril signaling pathways. Cur-
rently, it remains unclear what factors might modulate the
MURF-1–based myofibril-to-nuclear signaling pathways.
One idea is that the titin kinase domain could play a role in
this process, because the MURF-1 binding site is located ad-
jacent to this domain (Centner et al., 2001).
In conclusion, we demonstrated that the central region of
MURF-1 targets to the M-line region and participates in its
structural integrity in cardiac myocytes, most likely through
its interaction with titin’s COOH-terminal A168–170 re-
gion. Interestingly, MURF-1 is an RBCC protein, a family
whose members have been referred to as “builders of master
scaffolds” because many are involved in the formation of
multiprotein complexes (for review see Borden, 2000).
Thus, perhaps additional factors, such as other MURF fam-
ily members, are involved in regulating M-line and thick fil-
ament structure through their interactions with MURF-1. It
is also striking that RING finger and RBCC proteins have
been implicated in ubiquitination pathways (for review
see Freemont, 2000). Consistent with this, recombinant
MURF-1 protein was recently reported to have ubiquitin li-
gase activity (Bodine et al., 2001). Moreover, MURF-1
 
 
 
/
 
 
 
mice were resistant to skeletal muscle atrophy, suggesting
that MURF-1 regulates the degradation of critical muscle
proteins (Bodine et al., 2001). These results and the results
from our study support our hypothesis that MURF-1 is in-
volved in a novel pathway responsible for titin structure and/
or turnover. Intriguingly, because MURF-1 also is a nuclear
component that binds to the transcriptional modulator
GMEB-1, MURF-1 may participate in both the regulation
of myofibril assembly and structure as well as muscle gene
expression. In support of our hypothesis, rat skeletal muscle
MURF-1 mRNA levels increased 10-fold in response to glu-
cocorticoid exposure (Bodine et al., 2001), which regulates
GMEB-1 transcriptional activity (Theriault et al., 1999;
Zeng et al., 2000b). Future studies are required to elucidate
whether the dual localization of MURF-1 to myofibrils and
nuclei is a result of dynamic SUMO modification.
 
Materials and methods
 
Y2H interaction studies
 
For a survey of potential MURF-1 interactions, a full-length MURF-1
cDNA fragment was amplified from human skeletal muscle cDNA by PCR
(Saiki et al., 1985) and inserted into pAS2-1 (Matchmaker system II;
CLONTECH Laboratories, Inc.) to obtain a GAL4–BD fusion. For screen-
ing, bait constructs were transformed into 
 
Saccharomyces cerevisiae 
 
strain
CG1945, PJ69-4A (pAS2-1 bait), or L40c (BTM117c bait). For some
screens, the pAS2C-1 vector also was used (provided by T. Maeda, Univer-
sity of Tokyo). Subsequently, the cells were transformed with a human 
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skeletal muscle cDNA library into the pGAD10 prey vector (HL4010AB;
CLONTECH Laboratories, Inc.), essentially as described by the manufac-
turer. Cells were plated onto SD/Leu
 
 
 
/Trp
 
 
 
/His
 
 
 
 plates and incubated at
30
 
 
 
C until colonies appeared (after 
 
 
 
5 d). In screens where the pAS2-1
bait vector was used, the plates were supplemented with 1.5 mM 3-amino-
1,2,4-triazole (Sigma-Aldrich). Transformants were picked, restreaked onto
SD/Leu
 
 
 
/Trp
 
 
 
/His
 
 
 
 plates, and screened for 
 
 
 
-galactosidase activity.
 
 
 
-Galactosidase activity of the cells was measured either by colony lift fil-
ter assays using X-gal or in liquid culture using chlorophenol red 
 
 
 
-
 
D
 
-galac-
topyranoside, as described by the manufacturer (CLONTECH Laboratories,
Inc.). 
 
 
 
-Galactosidase–positive colonies were processed to lose the bait plas-
mid, and prey clones were recovered by electroporation of yeast DNA in
 
Escherichia coli
 
 and sequenced. To confirm binding, transformants were re-
transformed into yeast with either the bait or the vector. In addition, the
inserts of the bait and the prey vector were swapped and cotransformed into
yeast; identical results were obtained (unpublished data).
 
RT-PCR analysis of GMEB-1 mRNA transcripts
 
To determine the tissue distribution of GMEB-1 mRNA transcripts, com-
mercially available mRNAs (Stratagene) were reverse transcribed using
random hexamer primers and SuperScript reverse transcriptase according
to the manufacturer (Stratagene). To ensure that PCR products were not
amplified from contaminating genomic DNA, RNA also was incubated
without SuperScript reverse transcriptase. PCR amplifications were per-
formed essentially as described by Centner et al. (2000), using GMEB-1–
specific primers designed to amplify a 511-bp product (forward primer:
CGGAGGAGGGTGTAAAGAAAGACTC; reverse primer: GGGTGAGAT-
GACTGTGAACTGAGG). PCR products were verified by sequencing.
 
In vitro translation and GST pull-down experiments
 
In vitro transcription and translation were performed in the presence of
[
 
35
 
S]methionine (Amersham Pharmacia Biotech) using a TNT T7–coupled
reticulocyte lysate system according to the manufacturer’s instructions
(Promega). His
 
6
 
–GST double-tagged fusion proteins were obtained by
cloning into a modified pET9D vector. The constructs were transformed
into BL21-DE3 (CLONTECH Laboratories, Inc.) cells. Whole-cell lysates in
coating buffer (2
 
  
 
PBS, 1% Triton X-100) were prepared as previously de-
scribed (Studier et al., 1990). The GST fusion protein was immobilized on
glutathione–Sepharose 4B beads (Amersham Pharmacia Biotech) by incu-
bating 
 
 
 
200 
 
 
 
l of the lysate with 50 
 
 l of beads (50% slurry) for 1 h at
4 C. The beads were washed three times with coating buffer and resus-
pended in binding buffer (20 mM Tris, pH 7.4, 100 mM KCl, 1 mM EDTA,
1% Triton X-100, plus protease inhibitors). 5  l of in vitro–translated 
35S-
labeled proteins were added to 50  l of beads coated with 20  g of bound
GST fusion proteins in 300  l binding buffer. The mixture was incubated
for 1.5 h at 4 C, washed three times with binding buffer, and resuspended
in SDS sample buffer. The protein complexes were fractionated by SDS-
PAGE using 15% gels. The gels were fixed (20% methanol, 10% acetic
acid), stained with Coomassie blue, treated with Amplify (Amersham Phar-
macia Biotech), dried, and exposed using BioMax MR-1 film (Eastman
Kodak Co.). The results of the Coomassie blue staining confirmed that
equal amounts of each GST fusion protein were bound to the beads in the
different samples (unpublished data).
Cell culture and transfection procedures
For myocyte expression studies, cDNAs containing the entire open reading
frame of MURF-1 (residues 1–565) and subfragments of MURF-1, corre-
sponding to its 82 NH2-terminal residues, central 243 residues, and 85
COOH-terminal residues (Fig. 2), were amplified by PCR, using total hu-
man skeletal cDNA as a template. The MURF-1 cDNA sequence has been
deposited in the GenBank/EMBL/DDBJ data library under accession no.
AJ291713 (Centner et al., 2001). The full-length MURF-1 was cloned into
pEGFP-N1 (CLONTECH Laboratories, Inc.). The primers used to generate
the MURF-1 fragments were: 475S/720R for RING, 1525R/685S for RING-
less, 475S/1413R for Tailless, 685S/1413R for Central, and 1370S/1525R
for Tail, and the fragments were cloned into pEGFP-C1 (CLONTECH Labo-
ratories, Inc.). Similarly, titin fragments corresponding to the MURF-1
binding site, A168–A170, the COOH-terminally located kinase domain,
and M-line Ig domains were amplified from total human cDNA and cloned
into pEGFP-C1. The full-length human cardiac titin accession no. in the
GenBank/EMBL/DDBJ data library is X90568, and primers (listed as base
pairs) used to generate the titin fragments were: 73419S/74402R for A168–
170, 74254S/75345R for titin kinase, 74397S/75242R for mutated acti-
vated titin kinase, 75343S/76280R for M1-M2-M3, and 79177S/80918R
for M8-M9-M10. Recombinant pEGFP-C1 constructs were purified using
Qiagen columns (QIAGEN) before transfection into myocytes. Plasmids
were verified by sequencing. To rule out any potential artifacts resulting
from the GFP tag, pCMVmyc-MURF1 constructs, as well as constructs en-
coding MURF-1 with the GFP tag at its COOH-terminal end, were gener-
ated (Gregorio et al., 1998) and transfected into cardiac myocytes. Identi-
cal results were obtained (unpublished data).
Cardiac myocytes were prepared from 6-d embryonic chick hearts and
cultured as described previously (Gregorio and Fowler, 1995). Isolated cells
were plated in 35-mm tissue culture dishes containing 12-mm round cover-
slips (10
6 cells/dish). 15–20% of the cells in our primary cultures are fibro-
blasts. 24 h after plating, cultured myocytes were washed two times in Opti-
MEM, placed in 800  l fresh OptiMEM, and returned to the incubator while
DNA liposome complexes were prepared using LipofectAmine Plus re-
agents. In brief, 1  g plasmid was mixed with 6  l PLUS Reagent in 100  l
serum-free OptiMEM and incubated at room temperature for 15 min. Next,
4  l of LipofectAmine reagent were added to 100  l of OptiMEM and mixed
with the DNA–PLUS reagent solution. After 15 min, the DNA–lipid com-
plexes were added dropwise to the culture dish. 3 h later, 1 ml of minimal
essential medium (10% FBS; Hyclone Laboratories, Inc.) was added to the
dish. 3–6 d later, cells were gently washed with PBS and fixed with 2%
formaldehyde in PBS for 10 min. Coverslips were washed and stored in PBS
at 4 C until staining. Over 200 transfected cells per construct were analyzed.
Our transfection efficiencies ranged from 10–40%. All tissue culture re-
agents (except where noted) were purchased from Life Technologies.
Indirect immunofluorescence microscopy
Primary cultures of rat cardiac myocytes were isolated and maintained as
previously described (Gustafson et al., 1987). Transfected cardiac myo-
cytes were essentially stained as described by Gregorio et al. (1998). Cells
were fixed in 2% formaldehyde–PBS for 10 min, washed in PBS, and per-
meabilized in 0.2% Triton X-100–PBS for 15 min. The coverslips were pre-
incubated in 2% BSA, 1% normal donkey serum–PBS for 1 h to minimize
nonspecific binding of antibodies. For double-labeling protocols, cells
were incubated with affinity-purified rabbit polyclonal antibodies specific
to MURF-1 (5–10  g/ml) (Centner et al., 2001), followed by Cy2-conju-
gated goat anti–rabbit IgG (1:600), and incubated with monoclonal sarco-
meric anti– -actinin antibodies (1:1,500) (EA-53; Sigma-Aldrich) followed
by goat anti–mouse Texas red–conjugated IgG (1:600). For staining GFP-
transfected cells, well-characterized antibodies were used against various
sarcomeric components, including monoclonal anti-titin T11 antibodies
(1:1,000; Sigma-Aldrich), monoclonal anti-myosin antibodies F59 (1:10;
provided by F. Stockdale, Stanford University, Stanford, CA), rabbit anti-
titin M-line–specific antibodies (1:100; Centner et al., 2001), anti-titin N2A
antibodies (10  g/ml; Centner et al., 2000), rabbit anti–MyBP-C antibodies
(1:50; Linke et al., 1999), monoclonal anti-titin AB5 (1:3 of cultured super-
natant; provided by John Trinick, University of Leeds, Leeds, UK) (Whiting
et al., 1989), monoclonal anti-myomesin B4 antibodies (1:50 of cultured
supernatant; provided by J.C. Perriard, Swiss Federal Institute of Technol-
ogy, Zurich, Switzerland) (Grove et al., 1984), and Texas red–conjugated
phalloidin (1:200; Molecular Probes Inc.). The staining was followed by
incubation with Texas red–conjugated goat anti–mouse IgG plus IgM
(1:600) or Texas red–conjugated donkey anti–rabbit antibodies (1:700) for
45 min. To identify nuclei in some experiments, fixed cells were also incu-
bated in a DAPI stain (10  g/ml; Sigma-Aldrich) for 5 min at room temper-
ature before the final washing steps. Note, because of the intense diffuse-
ness of soluble titin–GFP fusion proteins in transfected cells, we extracted
soluble proteins with cytoskeletal (myofibril) stabilization buffer before fix-
ation in some experiments (Gregorio and Fowler, 1995). For triple-labeling
studies, a cascade blue–conjugated secondary antibody was used (1:200).
All coverslips were mounted on slides using Aqua Poly/Mount (Poly-
sciences, Inc.) and subsequently analyzed on a Zeiss Axiovert microscope
using a 100  (NA 1.3) objective, and micrographs were recorded as digi-
tal images on a SenSys cooled HCCD (Photometrics). For triple-labeling
studies, transfected cells were analyzed on a DeltaVision Deconvolution
Model D-OL Olympus microscope with a 60  objective (1.4 NA) using a
Photometrics Series 300 CCD camera (Applied Precision). Images were
processed for presentation using Adobe Photoshop
® 6.0. All secondary an-
tibodies were purchased from Jackson ImmunoResearch Laboratories, ex-
cept the Cy2-conjugated antibodies, which were purchased from Pierce
Chemical Co.
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